-
-
-
-
-
-
-
Intra-Cellular Therapies (ITCI) Announces Publication of Lumateperone Pivotal Phase 3 Study in Bipolar Depression in The American Journal of Psychiatry
-
-
-
-
-
-
-
Intra-Cellular Therapies (ITCI) Highlights Lumateperone Presentations at ACNP
-
-
-
-
-
-
-
Pre-Open Movers 08/05: (ALLK) (MBIO) (TXT) Higher; (GLYC) (CARS) (DO) (more...)
-
-
-
-
-
-
-
Intra-Cellular Therapies Reports First Quarter 2019 Financial Results and Provides Corporate Update
-
-
-
14,982 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

